Literature DB >> 9292517

Mutations in the murine fitness 1 gene result in defective hematopoiesis.

M D Potter1, S G Shinpock, R A Popp, V Godfrey, D A Carpenter, A Bernstein, D K Johnson, E M Rinchik.   

Abstract

Identification and characterization of mutations that disrupt normal hematopoiesis are essential for understanding the genetic pathways that control the development and regulation of the mammalian hematopoietic system. Previously, the fitness 1 gene was identified by five, independent mutations in N-ethyl-N-nitrosourea (ENU) saturation mutagenesis experiments within the albino (c) region of mouse chromosome 7 (MMU7). We report here that fit1 mutants are anemic, display numerous peripheral blood defects, and are deficient in early hematopoietic progenitor cell populations. The number of both erythroid and myeloid progenitors, as well as B cells, are reduced. These results implicate fit1 involvement in normal hematopoiesis and suggest that further characterization of the fit1 gene, and the five presumed point mutations of the gene, will lead to an improved understanding of normal hematopoiesis in the mouse.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9292517

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  N-ethyl-N-nitrosourea mutagenesis of a 6- to 11-cM subregion of the Fah-Hbb interval of mouse chromosome 7: Completed testing of 4557 gametes and deletion mapping and complementation analysis of 31 mutations.

Authors:  E M Rinchik; D A Carpenter
Journal:  Genetics       Date:  1999-05       Impact factor: 4.562

2.  Functional annotation of mammalian genomic DNA sequence by chemical mutagenesis: a fine-structure genetic mutation map of a 1- to 2-cM segment of mouse chromosome 7 corresponding to human chromosome 11p14-p15.

Authors:  Eugene M Rinchik; Donald A Carpenter; Dabney K Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-15       Impact factor: 11.205

3.  Role of the clathrin adaptor PICALM in normal hematopoiesis and polycythemia vera pathophysiology.

Authors:  Yuichi Ishikawa; Manami Maeda; Mithun Pasham; Francois Aguet; Silvia K Tacheva-Grigorova; Takeshi Masuda; Hai Yi; Sung-Uk Lee; Jian Xu; Julie Teruya-Feldstein; Maria Ericsson; Ann Mullally; John Heuser; Tom Kirchhausen; Takahiro Maeda
Journal:  Haematologica       Date:  2014-12-31       Impact factor: 9.941

4.  Mutations in the clathrin-assembly gene Picalm are responsible for the hematopoietic and iron metabolism abnormalities in fit1 mice.

Authors:  Mitchell L Klebig; Melissa D Wall; Mark D Potter; Erica L Rowe; Donald A Carpenter; Eugene M Rinchik
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-27       Impact factor: 11.205

5.  The clathrin assembly protein PICALM is required for erythroid maturation and transferrin internalization in mice.

Authors:  Mai Suzuki; Hirokazu Tanaka; Akira Tanimura; Kenji Tanabe; Natsuko Oe; Shinya Rai; Syunsuke Kon; Manabu Fukumoto; Kohji Takei; Takaya Abe; Itaru Matsumura; Yuzuru Kanakura; Toshio Watanabe
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

6.  Clathrin assembly protein CALM plays a critical role in KIT signaling by regulating its cellular transport from early to late endosomes in hematopoietic cells.

Authors:  Shinya Rai; Hirokazu Tanaka; Mai Suzuki; Honami Ogoh; Yasuhiro Taniguchi; Yasuyoshi Morita; Takahiro Shimada; Akira Tanimura; Keiko Matsui; Takafumi Yokota; Kenji Oritani; Kenji Tanabe; Toshio Watanabe; Yuzuru Kanakura; Itaru Matsumura
Journal:  PLoS One       Date:  2014-10-03       Impact factor: 3.240

Review 7.  The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis?

Authors:  Eugenia Quiros Roldan; Giorgio Biasiotto; Paola Magro; Isabella Zanella
Journal:  Pharmacol Res       Date:  2020-05-13       Impact factor: 7.658

8.  The PICALM protein plays a key role in iron homeostasis and cell proliferation.

Authors:  Paula B Scotland; Jessica L Heath; Amanda E Conway; Natasha B Porter; Michael B Armstrong; Jennifer A Walker; Mitchell L Klebig; Catherine P Lavau; Daniel S Wechsler
Journal:  PLoS One       Date:  2012-08-30       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.